Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (231-240 of 785) with videos related to

Pageof 79
Sort By:
Kidney International Reports|January 14, 2026
Impact of Proteinuria on Renal Outcomes in the BALANCE TrialEric L Wallace, Christoph Wanner, Giovanni Piotti, et al.
Diabetes & Vascular Disease Research|December 14, 2020
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME<sup>®</sup>Gisle Langslet, Bernard Zinman, Christoph Wanner, et al.
Endocrinology, Diabetes & Metabolism|December 27, 2022
Potassium management with finerenone: Practical aspectsChristoph Wanner, Paola Fioretto, Csaba P Kovesdy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 19, 2011
The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS studyAndreas Schneider, Christiane Drechsler, Vera Krane, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 8, 2017
Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patientsBruce E Reidenberg, Christoph Wanner, Bruce Polsky, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 16, 2010
Changes in parathyroid hormone, body mass index and the association with mortality in dialysis patientsChristiane Drechsler, Diana C Grootendorst, Elisabeth W Boeschoten, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2010
Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapyDetlef H Krieter, Regina Fischer, Karin Merget, et al.
The American Journal of Cardiology|July 31, 2014
Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry diseaseJohannes Krämer, Markus Niemann, Stefan Störk, et al.
JIMD Reports|February 23, 2013
Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry DiseaseMarkus Niemann, Arndt Rolfs, Anne Giese, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 30, 2013
Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa)Fabian Hammer, Vera Krane, Stefan Störk, et al.
Pageof 79

Showing results (231-240 of 785) with videos related to

Sort By:
Pageof 79
Kidney International Reports|January 14, 2026
Impact of Proteinuria on Renal Outcomes in the BALANCE TrialEric L Wallace, Christoph Wanner, Giovanni Piotti, et al.
Diabetes & Vascular Disease Research|December 14, 2020
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME<sup>®</sup>Gisle Langslet, Bernard Zinman, Christoph Wanner, et al.
Endocrinology, Diabetes & Metabolism|December 27, 2022
Potassium management with finerenone: Practical aspectsChristoph Wanner, Paola Fioretto, Csaba P Kovesdy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 19, 2011
The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS studyAndreas Schneider, Christiane Drechsler, Vera Krane, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 8, 2017
Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patientsBruce E Reidenberg, Christoph Wanner, Bruce Polsky, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 16, 2010
Changes in parathyroid hormone, body mass index and the association with mortality in dialysis patientsChristiane Drechsler, Diana C Grootendorst, Elisabeth W Boeschoten, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2010
Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapyDetlef H Krieter, Regina Fischer, Karin Merget, et al.
The American Journal of Cardiology|July 31, 2014
Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry diseaseJohannes Krämer, Markus Niemann, Stefan Störk, et al.
JIMD Reports|February 23, 2013
Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry DiseaseMarkus Niemann, Arndt Rolfs, Anne Giese, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 30, 2013
Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa)Fabian Hammer, Vera Krane, Stefan Störk, et al.
Pageof 79